The healthcare system is often described as broken, but as Charles Sauer explained during a recent event hosted by the Mises Institute, the solutions already exist. The challenge is not creating better models of care—it’s removing the government policies that prevent them from flourishing. Recorded on June 27 in Windham, Read more…
A bipartisan effort in Congress seeks to reinforce First Amendment protections by preventing federal officials from pressuring private companies to censor lawful speech. In a new RealClearMarkets column, Market Institute Senior Fellow Norm Singleton examines the Justice Against Weaponized Bureaucratic Overreach to Networked Expression (JAWBONE) Act and explains why it Read more…
A new opinion piece by Market Institute President Charles Sauer in RealClearMarkets argues that policymakers should resist efforts to ban personalized pricing, warning that government intervention would undermine consumer choice and market efficiency. As retailers like Kroger and Walmart adopt digital shelf labels, critics have raised concerns over so-called “surveillance Read more…
A newly published paper in The Milbank Quarterly adds to the growing body of evidence that the federal 340B Drug Pricing Program has strayed far from its original purpose, strengthening the case for meaningful congressional reform. In a recent RealClearMarkets commentary, Market Institute Senior Fellow Norm Singleton highlights Stretching Scarce Read more…
A new RealClearHealth op-ed by Dr. Craig Wax argues that if Congress is serious about reducing healthcare costs and increasing competition, lawmakers must reform one of the federal government’s biggest distortions: Medicare’s unequal payment system. Dr. Wax explains how current Medicare policy allows hospital systems to charge significantly more than Read more…
The American Innovation and Choice Online Act (AICOA) is back before Congress, and in a new RealClearMarkets op-ed, Market Institute Senior Fellow Norm Singleton argues lawmakers should finally let the legislation die. Comparing the bill to Dr. Frankenstein’s infamous creation, Singleton writes that Senators Amy Klobuchar and Charles Grassley continue Read more…
New RealClearHealth op-ed from Charles Sauer highlights why Washington must remove barriers to early diagnosis and treatment. Most Americans say they would want to know if they had Alzheimer’s disease years before symptoms appeared. Thanks to advances in blood-based testing and new therapies, early detection can now give patients and Read more…
In a new column published in RealClearMarkets, Market Institute Senior Fellow Norm Singleton examines recent testimony from FTC Chair Andrew Ferguson and Commissioner Mark Meador before the Senate Commerce Committee. Singleton argues that Ferguson’s remarks represent a significant departure from the expansive antitrust philosophy that characterized the previous FTC leadership. Read more…
Innovation has been central to America’s economic success since the nation’s founding. In a new column for RealClearMarkets, Market Institute President Charles Sauer argues that policymakers should remember the vital role patents have played in driving growth, investment, and technological advancement. Sauer traces the history of patents from the earliest Read more…
Market Institute President Charles Sauer joined the Scott Sloan Show on 700 WLW to discuss the need for Medicare Advantage reform as policymakers focus on reducing waste, fraud, and abuse in federal healthcare programs. During the conversation, Sauer explained how Medicare Advantage provides valuable choices for seniors but also contains Read more…